Filanesib in combination with pomalidomide and dexamethasone in refractory MM patients: safety and efficacy, and association with alpha 1-acid glycoprotein (AAG) levels. Phase Ib/II Pomdefil clinical trial conducted by the Spanish MM group

  1. Ocio, E.M.
  2. Motlló, C.
  3. Rodríguez-Otero, P.
  4. Martínez-López, J.
  5. Cejalvo, M.J.
  6. Martín-Sánchez, J.
  7. Bladé, J.
  8. García-Malo, M.D.
  9. Dourdil, M.V.
  10. García-Mateo, A.
  11. de Arriba, F.
  12. García-Sanz, R.
  13. de la Rubia, J.
  14. Oriol, A.
  15. Lahuerta, J.-J.
  16. San-Miguel, J.F.
  17. Mateos, M.-V.
Aldizkaria:
British Journal of Haematology

ISSN: 1365-2141 0007-1048

Argitalpen urtea: 2021

Alea: 192

Zenbakia: 3

Orrialdeak: 522-530

Mota: Artikulua

DOI: 10.1111/BJH.16788 GOOGLE SCHOLAR

Garapen Iraunkorreko Helburuak